<?xml version="1.0" encoding="ISO-8859-1"?>
<!DOCTYPE ichicsr SYSTEM "http://www.accessdata.fda.gov/xml/icsr-xml-v2.1.dtd">
<ichicsr lang="en">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4149690_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125152631</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>6</safetyreportversion>
		<safetyreportid>PHHO2012TR003614</safetyreportid>
		<primarysourcecountry>TR</primarysourcecountry>
		<occurcountry>TR</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>20130125</transmissiondate>
		<reporttype>2</reporttype>
		<serious>1</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>1</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>20120301</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>20130122</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHO2012TR003614</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reporterfamilyname>Not Available</reporterfamilyname>
			<reportercountry>TR</reportercountry>
			<qualification>1</qualification>
			<sponsorstudynumb>CACZ885G2301E1</sponsorstudynumb>
			<observestudytype>1</observestudytype>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>--</patientinitial>
			<patientinvestigationnumb>202</patientinvestigationnumb>
			<patientonsetage>11</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientweight>32</patientweight>
			<patientheight>136</patientheight>
			<patientsex>1</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Pyrexia</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20120227</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Pancytopenia</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20120229</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Aspiration bone marrow</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Macrophage activation syndrome</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Macrophage activation syndrome</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Histiocytosis haematophagic</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120229</reactionstartdate>
				<reactionfirsttime>92</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionlasttime>8</reactionlasttime>
				<reactionlasttimeunit>804</reactionlasttimeunit>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<test>
				<testname>Alanine aminotransferase</testname>
				<hightestrange>less than 39</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Alanine aminotransferase</testname>
				<hightestrange>less than 39</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Aspartate aminotransferase</testname>
				<hightestrange>less than 51</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Aspartate aminotransferase</testname>
				<hightestrange>less than 51</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Aspartate aminotransferase</testname>
				<hightestrange>less than 51</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Aspiration bone marrow</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Blood creatinine</testname>
				<testresult>0.40</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange>0.53</lowtestrange>
				<hightestrange>0.79</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>Blood fibrinogen</testname>
				<lowtestrange>180</lowtestrange>
				<hightestrange>350</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Blood fibrinogen</testname>
				<testresult>206</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange>219</lowtestrange>
				<hightestrange>403</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Blood lactate dehydrogenase</testname>
				<testresult>1206</testresult>
				<testunit>U/l</testunit>
				<hightestrange>less than 332</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Blood lactate dehydrogenase</testname>
				<testresult>560</testresult>
				<testunit>U/l</testunit>
				<hightestrange>less than 332</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Blood triglycerides</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Blood urea increased</testname>
				<lowtestrange>5</lowtestrange>
				<hightestrange>18</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Blood uric acid</testname>
				<testresult>1.26</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange>2.2</lowtestrange>
				<hightestrange>5.8</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120122</testdate>
				<testname>C-reactive protein</testname>
				<hightestrange>less than 0.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120123</testdate>
				<testname>C-reactive protein</testname>
				<hightestrange>less than 0.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>C-reactive protein</testname>
				<hightestrange>less than 0.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>C-reactive protein</testname>
				<hightestrange>less than 0.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>C-reactive protein</testname>
				<hightestrange>less than 0.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Cytomegalovirus test</testname>
				<lowtestrange>0</lowtestrange>
				<hightestrange>6.0</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Haematocrit</testname>
				<testresult>35.5</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Haematocrit</testname>
				<testresult>30.8</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Haematocrit</testname>
				<testresult>30.4</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Haematocrit</testname>
				<testresult>32.3</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Haematocrit</testname>
				<testresult>32.7</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>Haematocrit</testname>
				<testresult>36.1</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Haemoglobin</testname>
				<testresult>12.3</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Haemoglobin</testname>
				<testresult>10.4</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Haemoglobin</testname>
				<testresult>10.2</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Haemoglobin</testname>
				<testresult>10.8</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Haemoglobin</testname>
				<testresult>11.5</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120306</testdate>
				<testname>Haemoglobin</testname>
				<testresult>11.2</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>Haemoglobin</testname>
				<testresult>12.2</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>23.7</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>23.0</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>22.1</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>22.3</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>24</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>23</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>150000</lowtestrange>
				<hightestrange>450000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>150000</lowtestrange>
				<hightestrange>450000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>156</lowtestrange>
				<hightestrange>373</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>156</lowtestrange>
				<hightestrange>373</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>156</lowtestrange>
				<hightestrange>373</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>156</lowtestrange>
				<hightestrange>373</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120306</testdate>
				<testname>Platelet count</testname>
				<hightestrange>&gt;130000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Protein total</testname>
				<testresult>8.46</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>6.0</lowtestrange>
				<hightestrange>8.0</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Protein total</testname>
				<testresult>8.69</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>6.0</lowtestrange>
				<hightestrange>8.0</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>Red blood cell sedimentation rate</testname>
				<hightestrange>less than 20 min/hr</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Red blood cell sedimentation rate</testname>
				<hightestrange>less than 20 min/hr</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Red blood cell sedimentation rate</testname>
				<hightestrange>less than 20 min/hr</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Red blood cell sedimentation rate</testname>
				<hightestrange>less than 20 min/hr</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Red cell distribution width</testname>
				<testresult>18.9</testresult>
				<testunit>%</testunit>
				<lowtestrange>11.8</lowtestrange>
				<hightestrange>14.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Red cell distribution width</testname>
				<testresult>19.2</testresult>
				<testunit>%</testunit>
				<lowtestrange>11.8</lowtestrange>
				<hightestrange>14.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Red cell distribution width</testname>
				<testresult>18.9</testresult>
				<testunit>%</testunit>
				<lowtestrange>11.8</lowtestrange>
				<hightestrange>14.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Red cell distribution width</testname>
				<testresult>18.3</testresult>
				<testunit>%</testunit>
				<lowtestrange>11.8</lowtestrange>
				<hightestrange>14.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>Red cell distribution width</testname>
				<testresult>18.8</testresult>
				<testunit>%</testunit>
				<lowtestrange>11.8</lowtestrange>
				<hightestrange>14.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>Serum ferritin increased</testname>
				<testresult>636</testresult>
				<testunit>ng/ml</testunit>
				<lowtestrange>24</lowtestrange>
				<hightestrange>336</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Serum ferritin increased</testname>
				<testresult>864</testresult>
				<testunit>ng/ml</testunit>
				<lowtestrange>24</lowtestrange>
				<hightestrange>336</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Serum ferritin increased</testname>
				<testresult>583.6</testresult>
				<testunit>ng/ml</testunit>
				<lowtestrange>24</lowtestrange>
				<hightestrange>336</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120306</testdate>
				<testname>Serum ferritin increased</testname>
				<testresult>155</testresult>
				<testunit>ng/ml</testunit>
				<lowtestrange>24</lowtestrange>
				<hightestrange>336</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>White blood cell count</testname>
				<lowtestrange>4000</lowtestrange>
				<hightestrange>105000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>White blood cell count</testname>
				<lowtestrange>4000</lowtestrange>
				<hightestrange>105000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120306</testdate>
				<testname>White blood cell count</testname>
				<lowtestrange>4000</lowtestrange>
				<hightestrange>105000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>ACZ885 </medicinalproduct>
				<obtaindrugcountry>TR</obtaindrugcountry>
				<drugauthorizationnumb>BLA 125319</drugauthorizationnumb>
				<drugauthorizationcountry>TR</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.8</drugstructuredosagenumb>
				<drugstructuredosageunit>012</drugstructuredosageunit>
				<drugdosagetext>0.80 ml, UNK</drugdosagetext>
				<drugdosageform>Powder for sol for inj</drugdosageform>
				<drugadministrationroute>058</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Juvenile arthritis</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20111130</drugstartdate>
				<drugstartperiod>92</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug>4</actiondrug>
				<activesubstance>
					<activesubstancename>CANAKINUMAB</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>ACZ885 </medicinalproduct>
				<obtaindrugcountry>TR</obtaindrugcountry>
				<drugauthorizationnumb>BLA 125319</drugauthorizationnumb>
				<drugauthorizationcountry>TR</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.86</drugstructuredosagenumb>
				<drugstructuredosageunit>012</drugstructuredosageunit>
				<drugdosagetext>0.86 ml, UNK</drugdosagetext>
				<drugdosageform>Powder for sol for inj</drugdosageform>
				<drugadministrationroute>058</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20111226</drugstartdate>
				<drugstartperiod>92</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug>4</actiondrug>
				<activesubstance>
					<activesubstancename>CANAKINUMAB</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>ACZ885 </medicinalproduct>
				<obtaindrugcountry>TR</obtaindrugcountry>
				<drugauthorizationnumb>BLA 125319</drugauthorizationnumb>
				<drugauthorizationcountry>TR</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.85</drugstructuredosagenumb>
				<drugstructuredosageunit>012</drugstructuredosageunit>
				<drugdosagetext>0.85 ml, UNK</drugdosagetext>
				<drugdosageform>Powder for sol for inj</drugdosageform>
				<drugadministrationroute>058</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120123</drugstartdate>
				<drugstartperiod>92</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug>4</actiondrug>
				<activesubstance>
					<activesubstancename>CANAKINUMAB</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>ACZ885 </medicinalproduct>
				<obtaindrugcountry>TR</obtaindrugcountry>
				<drugauthorizationnumb>BLA 125319</drugauthorizationnumb>
				<drugauthorizationcountry>TR</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.88</drugstructuredosagenumb>
				<drugstructuredosageunit>012</drugstructuredosageunit>
				<drugdosagetext>0.88 ml, UNK</drugdosagetext>
				<drugdosageform>Powder for sol for inj</drugdosageform>
				<drugadministrationroute>058</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120222</drugstartdate>
				<drugstartperiod>92</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug>4</actiondrug>
				<activesubstance>
					<activesubstancename>CANAKINUMAB</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHO2012TR003614, is an initial report received on 01 Mar 2012, from clinical study CACZ885G2301E1. This 11-year-old male subject (centre number 145, subject number 202) was enrolled in study protocol CACZ885G2301E1, an open-label extension study of canakinumab (ACZ885) in subjects with Systemic Juvenile Idiopathic Arthritis (SJIA) and active systemic manifestations.

The subject's medical history included fever. The subject does not have a history of autoinflammatory/autoimmune conditions, flaring of the autoinflammatory/autoimmune condition during the current event, previous macrophage activation syndrome / hemophagocytic lymphohistiocytosis and other medically significant chronic condition(s). The subject received open label study medication on 30 Nov 2011 at a dose of 0.80 ml. On 29 Feb 2012, the subject was hospitalised with the complaint of non-remitting high fever of unknown etiology since 3 days. The subject does not present with signs or symptoms like concurrent or recent infection, sepsis, liver/spleen enlargement, enlargement of the lymph nodes, hemorrhagic manifestations, CNS dysfunction and other organ involvement (i.e., renal, cardiac). It was noted that subject had pancytopenia. On 29 Feb 2012, the laboratory investigation revealed; WBC count 1800(4000-105000, platelets count 84000 (150000-450000), ESR (erythrocyte sedimentation rate); 26(&lt;20 min/hr), CRP(C reactive protein) 16(&lt;8 mg/l), ferritin 636(24-336) and fibrinogen 320 (180-350). On 01 Mar 2012, the subject was transferred to another hospital. The subject&#8217;s underwent ESR, coagulation factors (i.e., fibrinogen, etc), leukocyte count, differential, CRP, hemoglobin, triglycerides, ferritin, electrolytes, platelet count, liver function tests (Bilirubin, AST, LFT, AP, LDH, etc) and evidence of hemophagocytosis in the bone marrow or other organ (i.e. liver). On 01 Mar 2012 subject's WBC was 32000, platelets 112000, 'LDH' 1206, ferratin 864, fibrinogen and on the same day, bone marrow aspiration showed increased histocytes, hemophagotic cell and suggestive MAS. On 05 Mar 2012, ALT was 20 (&lt; 39) and AST was 23 (&lt;51).  On 06 Mar 2012, subject's hemoglobin was 11.2 (13.6-17), WBC count was 4600, thrombocyte count 98000(&gt; 130000), ferritin 155.The investigator reported that viral serology was negative so viral infection was ruled out. So the investigator diagnosed and provided the final event as Macrophage Activation Syndrome. Subject's bone marrow aspiration results were normal. On an unknown date subject's AST (Aspartate aminotransferase) was 52, ALT (Alanine aminotransferase) was 14 and triglycerides were normal. The subject was treated with methyl prednisone, immunomodulation therapy (cyclosporine) and IVIG Therapy. There was no action taken with the study medication due to the events (MAS and viral infection). At the time of the report, the subject was completely recovered from the event on an unknown date. These events were considered serious (hospitalisation) by the investigator.

The investigator reported that the events were suspected to be related to treatment with the study medication. 

Follow up received on 02 Mar 2012, prior to the circulation on the previous report: Updated information on events diagnosis with its causality assessment and outcome.

Follow up received on 06 Mar 2012: Updated information on laboratory investigations and final diagnosis.

Follow-up report received on 09 Mar 2012: Updated the outcome of the event as complete recovery.

Follow up (checklist) received on 24 Dec 2012: Updated event verbatim, symptom of the event and laboratory investigation.

Follow-up macrophage activation syndrome checklist received on 10 Jan 2013: Updated medical history, symptoms, treatment medications and laboratory reports.

Follow-up report received on 22 Jan 2013: Updated the laboratory reports.</narrativeincludeclinical>
				<sendercomment>The reported serious adverse event MAS is expected as per current IB.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr>
